What you need to know The prevalence of heart failure across Europe is estimated to be 1-2% of adults.1 In the UK, this places a substantial burden on patients and healthcare resources, including ...

For years, researchers have suspected that a hormone called relaxin could be an effective treatment for certain cardiovascular diseases. It helps counteract scarring (fibrosis), prevents veins and ...

After a heart attack, the heart struggles to recoup and maintain energy. One third of patients develop heart failure as a ...

After a heart attack, the heart struggles to recoup and maintain energy. One-third of patients develop heart failure as a result—a condition that impacts 6.8 million Americans and carries a high ...

Researchers at the Nora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, and the University of Utah School of Medicine, have demonstrated that a gene therapy can ...

A @HopkinsMedicine-led study offers strong evidence that adults with coexisting prediabetes and hypertension are at a higher ...

Japan has approved ground-breaking stem-cell treatments for Parkinson's and severe heart failure, one of the manufacturers ...

The update comes as the therapy’s regulatory application awaits a decision from the U.S. Food and Drug Administration later ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Beta-blockers did not improve clinical outcomes after ...

The gut microbiome plays an important role in many aspects of health, from digestion and immune function to metabolic balance and neurological processes.

Research into a popular sleeping aid has some scientists worried about long-term usage. A recent analysis of adults with ...

Segment showcases SynCardia Total Artificial Heart supporting patients with advanced heart failure and next-generation development programs ...